Indications/Uses
For the prevention and treatment of Iron deficiency anemia.
Dosage/Direction for Use
Missed Dose: If the patient misses a dose, just take the next dose and the subsequent doses at the usual recommended schedule, i.e., once a day.
Do not double the dose unless recommended by a doctor.
Do not double the dose unless recommended by a doctor.
Overdosage
Iron: Symptoms of acute Iron overdosage can be divided into four stages.
Stage I: occurs up to six hours after ingestion, the principal symptoms are vomiting and diarrhea. Other symptoms include hypotension (low blood pressure), tachycardia (rapid heartbeat) and central nervous system (CNS) depression ranging from lethargy (sleepiness) to coma (state of unconsciousness).
Stage II: may occur 6 to 24 hours after ingestion and is characterized by a temporary remission or signs of overdosage are decreased.
Stage III: gastrointestinal symptoms recur accompanied by shock, metabolic acidosis (increased acid in the blood), coma, hepatic necrosis (death of liver tissue), jaundice (yellowish color of the skin, eyes and other tissues), hypoglycemia (low blood sugar), kidney failure, and pulmonary edema (fluid in the lungs).
Stage IV: occur several weeks after ingestion and is characterized by gastrointestinal obstruction (blockage) and liver damage.
If the patient has taken more than the recommended dosage, consult a doctor or contact a Poison Control Center right away.
Stage I: occurs up to six hours after ingestion, the principal symptoms are vomiting and diarrhea. Other symptoms include hypotension (low blood pressure), tachycardia (rapid heartbeat) and central nervous system (CNS) depression ranging from lethargy (sleepiness) to coma (state of unconsciousness).
Stage II: may occur 6 to 24 hours after ingestion and is characterized by a temporary remission or signs of overdosage are decreased.
Stage III: gastrointestinal symptoms recur accompanied by shock, metabolic acidosis (increased acid in the blood), coma, hepatic necrosis (death of liver tissue), jaundice (yellowish color of the skin, eyes and other tissues), hypoglycemia (low blood sugar), kidney failure, and pulmonary edema (fluid in the lungs).
Stage IV: occur several weeks after ingestion and is characterized by gastrointestinal obstruction (blockage) and liver damage.
If the patient has taken more than the recommended dosage, consult a doctor or contact a Poison Control Center right away.
Administration
Should be taken on an empty stomach: May be taken w/ meals to reduce GI discomfort.
Contraindications
If the patient is allergic to any component in the product.
If the patient has primary hemochromatosis (a genetic condition characterized by excessive iron absorption), peptic ulcer, regional enteritis (inflammation of the intestines such as Crohn's disease), or ulcerative colitis (colon sores).
If the patient is receiving Iron injection or blood transfusions to avoid Iron overload.
If the patient has primary hemochromatosis (a genetic condition characterized by excessive iron absorption), peptic ulcer, regional enteritis (inflammation of the intestines such as Crohn's disease), or ulcerative colitis (colon sores).
If the patient is receiving Iron injection or blood transfusions to avoid Iron overload.
 ₱470){kind=link}